Compare · NTRA vs TRUP
NTRA vs TRUP
Side-by-side comparison of Natera Inc. (NTRA) and Trupanion Inc. (TRUP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NTRA and TRUP operate in Medical Specialities (Health Care), so they compete in similar markets.
- NTRA is the larger of the two at $47.03B, about 36.2x TRUP ($1.30B).
- Over the past year, NTRA is up 92.8% and TRUP is down 34.3% - NTRA leads by 127.1 points.
- TRUP has been more active in the news (14 items in the past 4 weeks vs 5 for NTRA).
- NTRA has more recent analyst coverage (25 ratings vs 13 for TRUP).
- Company
- Natera Inc.
- Trupanion Inc.
- Price
- $326.47-3.58%
- $29.64-0.07%
- Market cap
- $47.03B
- $1.30B
- 1M return
- +21.01%
- +20.98%
- 1Y return
- +92.76%
- -34.32%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2015
- News (4w)
- 5
- 14
- Recent ratings
- 25
- 13
Natera Inc.
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.
Trupanion Inc.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Latest NTRA
- PRESIDENT, CHIEF BUS. OFFICER Fesko John was granted 20,000 shares and sold $2,095,411 worth of shares (6,517 units at $321.53) as part of a pre-agreed trading plan, increasing direct ownership by 7% to 197,257 units (SEC Form 4) (tax liability)
- Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
- Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
- CO-FOUNDER Sheena Jonathan sold $1,951,942 worth of shares (6,000 units at $325.32) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 230,464 units (SEC Form 4)
- Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers
- CO-FOUNDER Sheena Jonathan sold $2,888,325 worth of shares (9,150 units at $315.66) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 236,464 units (SEC Form 4)
- EXECUTIVE CHAIRMAN Rabinowitz Matthew sold $641,800 worth of shares (2,000 units at $320.90) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form S-8 filed by Natera Inc.
- SEC Form 10-Q filed by Natera Inc.
- Natera Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest TRUP
- CEO Tooth Margaret converted options into 19,042 shares, covered exercise/tax liability with 7,000 shares and sold $15,633 worth of shares (491 units at $31.84), increasing direct ownership by 7% to 186,952 units (SEC Form 4) (withholding tax)
- Director Rubin Howard E converted options into 420 shares, increasing direct ownership by 0.18% to 233,288 units (SEC Form 4)
- Director Powell Bradley S converted options into 1,640 shares, increasing direct ownership by 86% to 3,546 units (SEC Form 4)
- Chief Legal Officer Bearman Asher converted options into 2,610 shares and covered exercise/tax liability with 841 shares, increasing direct ownership by 2% to 74,013 units (SEC Form 4) (for tax liability)
- Chief Administration Officer Mcgibney Brenna converted options into 6,430 shares and covered exercise/tax liability with 3,438 shares, increasing direct ownership by 26% to 14,437 units (SEC Form 4) (tax withholding)
- Chief Operating Officer Gallagher John R converted options into 6,794 shares and covered exercise/tax liability with 1,651 shares, increasing direct ownership by 16% to 37,346 units (SEC Form 4) (tax liability)
- EVP, North Am & Vet Strategy Weinrauch Steve converted options into 4,859 shares and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 5% to 81,740 units (SEC Form 4) (withholding tax)
- Director Rawlings Darryl converted options into 313 shares, increasing direct ownership by 1% to 25,151 units (SEC Form 4)
- Chief Financial Officer Qureshi Fawwad converted options into 13,746 shares, covered exercise/tax liability with 5,486 shares and sold $183,391 worth of shares (6,111 units at $30.01), increasing direct ownership by 103% to 4,230 units (SEC Form 4) (for withholding tax)
- EVP, Trupanion International Wheeler Simon converted options into 2,173 shares and covered exercise/tax liability with 1,085 shares, increasing direct ownership by 4% to 25,327 units (SEC Form 4) (for tax liability)